ABBV STOCK HITS RECORD ALL TIME HIGH

Discussion in 'AbbVie' started by anonymous, Jun 14, 2017 at 12:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    ABBV breaks thru and is up .28 in a major negative market !! So we have finally bottomed out and the rebound has begun IMO. Any thoughts b4 I buy more?
     

  2. anonymous

    anonymous Guest

    Because Trade war with China has no bearing on Pharma/Abbvie. Watch when Trump goes after Pharma pricing (if he ever does)
     
  3. anonymous

    anonymous Guest

    Stocks headed to $60s
     
  4. anonymous

    anonymous Guest


    yes ABBV up 2.6% today and headed thru 100 by week end. Buy now !
     
  5. anonymous

    anonymous Guest

    I could see 60 after ___ news breaks.
     
  6. anonymous

    anonymous Guest


    NO WAY !!!! YOU ARE A NEGATIVE PERSON !! OUR COMPANY WILL TAKE OFF AND HIT $125-150 THIS SUMMER !!! THE PIPELINE IS OUTSTANDING AND OUR LEADER IS A STRATEGIC PLANNER OF WORLD CLASS CALIBER. HE IS RECOGNIZED IN PHARMA AS ONE OF THE BEST AND HAS NUMEROUS HONORARY PHD'S.
     
  7. anonymous

    anonymous Guest

    Not only PHD's, but many Honorary GED's as well!
     
  8. anonymous

    anonymous Guest

    LOL Probably right !!!!!!!!!!!!!!!!
     
  9. anonymous

    anonymous Guest

    Abbv
    $89.23 USD −3.00 (3.25%)

    Yuk Yuk Yuk
     
  10. anonymous

    anonymous Guest

    Thanks to Trump, the entire market is in an unpredictable tizzy!
    It will settle down when the dust clears.
     
  11. anonymous

    anonymous Guest

    Not all bad. The May Dividend will buy more in reinvesting. Buckle up for a big second half of 2018.
     
  12. anonymous

    anonymous Guest

    Just placed buy order for 750 shares, max 90. This may be the bargain of the year if I get it. This stock will be pushing 125 to 150 by 3Q18 per financial pro's in pharma. Cant believe more aren't doing this. You must be dumb as a brick to not buy in. Wish I had more cash to put in, but wife needs a new car.
     
  13. anonymous

    anonymous Guest

    Baby needs a new pair of shoes.
     
  14. anonymous

    anonymous Guest

    Word is abbvie beats street tomorrow and reports EPS @ $1.80
    Let's see what Stock does.
     
  15. anonymous

    anonymous Guest

    Stock still has negative sentiment from Rova T. ONLY up 3.66%on beat. Bad news !!!!!!!
     
  16. anonymous

    anonymous Guest

    The share buy back of $7.5 billion is a smoke screen to boost crumbling stock.
    The Corporate Tax reform was not meant to let greedy CEOs like Rick to pull this BS move. Trump was an idiot giving these leechs a licence to steal.
     
  17. anonymous

    anonymous Guest

    Whoa, Vpak and Mavyret pulled in $919 million ? Looks like Jeff H. And Lootzie are getting the ball rolling. HCV is a small safety net for Abbvie, but nonetheless it's pulling in billions now.
     
  18. anonymous

    anonymous Guest

    Rest assured Ricky will take care of us. Just bought another 1,000 shares Love this place !!!!!!!!!!!!!!
     
  19. anonymous

    anonymous Guest

    The street knows risankizumab will tank in the psoriasis market. When more data comes out (soon) you'll see Abbv tank like after Rova T lie by Rick.
     
  20. anonymous

    anonymous Guest

    Ricks lying again at earnings call ? $7.5 B going to stock buy back NOT the fairy tale spun below

    Since that time, we've continued to contemplate the most effective ways to deploy our investment opportunities from tax reform to maximize the benefit and to support our business over the long term. Now with the benefit of tax reform, we expect to invest more aggressively in R&D, exploring opportunities to augment our early-stage pipeline and add additional R&D capabilities. In support of this, we plan to continue to expand our oncology presence in Northern California, with a focus on further driving R&D innovation.

    We also plan to invest more heavily in support of numerous products we expect to launch over the next 18 months, ensuring that these new therapies are well-positioned to achieve their maximum commercial potential. All of these actions demonstrate that tax reform is having the intended impact, creating new jobs and helping to stimulate U.S. investment.